lobbying_filings_raw: 3af5d910-68a9-47f0-8496-0591913141a9
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3af5d910-68a9-47f0-8496-0591913141a9 | Q3 | 33545 | ROCK & ASSOCIATES | 141936 | WOMEN'S INTERNATIONAL PHARMACY | 2016 | third_quarter | 2016-10-11T02:59:19.700000-04:00 | 11250.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/3af5d910-68a9-47f0-8496-0591913141a9/", "filing_uuid": "3af5d910-68a9-47f0-8496-0591913141a9", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2016, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/3af5d910-68a9-47f0-8496-0591913141a9/print/", "filing_document_content_type": "text/html", "income": "11250.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "James W. Rock", "dt_posted": "2016-10-11T02:59:19.700000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "517 C Street, NE", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20002", "registrant": {"id": 33545, "url": "https://lda.senate.gov/api/v1/registrants/33545/", "house_registrant_id": 30422, "name": "ROCK & ASSOCIATES", "description": "Government relations consultant.", "address_1": "517 C Street, NE", "address_2": null, "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20002", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "JAMES W. ROCK", "contact_telephone": "+1 703-627-8226", "dt_updated": "2025-02-03T11:57:31.624210-05:00"}, "client": {"id": 141936, "url": "https://lda.senate.gov/api/v1/clients/141936/", "client_id": 125, "name": "WOMEN'S INTERNATIONAL PHARMACY", "general_description": "Retail pharmacy.", "client_government_entity": false, "client_self_select": false, "state": "WI", "state_display": "Wisconsin", "country": "US", "country_display": "United States of America", "ppb_state": null, "ppb_state_display": null, "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2013-04-16"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 22837, "prefix": null, "prefix_display": null, "first_name": "JAMES", "nickname": null, "middle_name": "W", "last_name": "ROCK", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "LAW", "general_issue_code_display": "Law Enforcement/Crime/Criminal Justice", "description": "Proposals to amend the Controlled Substances Act to clarify the definition of \"dispense\" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 22837, "prefix": null, "prefix_display": null, "first_name": "JAMES", "nickname": null, "middle_name": "W", "last_name": "ROCK", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "Appropriations (H.R. 5054 and S. 2956) to fund the FDA implementation of compounding pharmacy regulations.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 22837, "prefix": null, "prefix_display": null, "first_name": "JAMES", "nickname": null, "middle_name": "W", "last_name": "ROCK", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 22837, "prefix": null, "prefix_display": null, "first_name": "JAMES", "nickname": null, "middle_name": "W", "last_name": "ROCK", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |